← Back to patent-cliff list
CAS 578-54-1
2-ethylaniline2-Ethylaniline
Codes: PAZO-001, Bromfenac Sodium-028
Application context (from source-drug indications)
Renal cell carcinomaPazopanib HydrochlorideSarcomaPazopanib HydrochlorideSoft tissue neoplasmPazopanib HydrochlorideEpistaxisPazopanib HydrochlorideHereditary haemorrhagic telangiectasiaPazopanib HydrochlorideSolitary fibrous tumourPazopanib HydrochlorideInflammatory diseaseBromfenac SodiumPostoperative painBromfenac Sodium眼睛发炎Bromfenac Sodium眼睛疼痛Bromfenac SodiumDry eye syndromeBromfenac Sodium黄斑水肿Bromfenac Sodium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Pazopanib Hydrochloride | Tier C — Watch / trade | - |
| Bromfenac Sodium | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-ethylaniline→2-ethyl-5-nitroaniline→3-methyl-6-nitro-1H-indazole→2,3-dimethyl-6-nitro-2H-indazole→2,3-dimethyl-2H-indazol-6-amine hydrochloride→2,4-dichloropyrimidine→N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine→N-(2-chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine→5-amino-2-methylbenzenesulfonamide
1-Ethyl-2-nitrobenzene→2-Ethylaniline→4-Bromobenzoyl chloride→(2-Amino-3-ethylphenyl)(4-bromophenyl)methanone→N,N-Dimethylformamide dimethyl acetal→[2-Amino-3-[3-(dimethylamino)prop-2-en-1-yl]phenyl](4-bromophenyl)methanone
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Taizhou GMP-like Site | 3-Methyl-6-nitroindazole Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | 2,3-Dimethyl-2H-indazol-6-amine hydrochloride Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | N-(2-chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 3-Amino-6-methylbenzenesulfonamide Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.